Search research articles
Contact Us
Filters
Showing results (1-10 of 16) with videos related to
Page
of 2
Sort By:
Current Opinion in Pharmacology
|
October 16, 2003
New technologies in therapeutic antibody development
O H Brekke, G Å Løset
Immunology Today
|
February 1, 1995
The structural requirements for complement activation by IgG: does it hinge on the hinge?
O H Brekke, T E Michaelsen, I Sandlie
Biological Chemistry
|
February 14, 1998
Identification and characterisation of C1q-binding phage displayed peptides
V Lauvrak, O H Brekke, O Ihle, et al.
Nature
|
September 5, 1996
Activation of complement by an IgG molecule without a genetic hinge
O H Brekke, T E Michaelsen, R Sandlin, et al.
Nature
|
June 17, 1993
Activation of complement by an IgG molecule without a genetic hinge
O H Brekke, T E Michaelsen, R Sandin, et al.
Protein Engineering, Design & Selection : PEDS
|
October 11, 2007
Functional phage display of two murine alpha/beta T-cell receptors is strongly dependent on fusion format, mode and periplasmic folding assistance
G Å Løset, E Lunde, B Bogen, et al.
European Journal of Immunology
|
July 1, 1993
The extended hinge region of IgG3 is not required for high phagocytic capacity mediated by Fc gamma receptors, but the heavy chains must be disulfide bonded
A Aase, I Sandlie, L Norderhaug, et al.
European Journal of Immunology
|
October 1, 1994
Human IgG isotype-specific amino acid residues affecting complement-mediated cell lysis and phagocytosis
O H Brekke, T E Michaelsen, A Aase, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 21, 1998
Comparisons of the ability of human IgG3 hinge mutants, IgM, IgE, and IgA2, to form small immune complexes: a role for flexibility and geometry
K H Roux, L Strelets, O H Brekke, et al.
Molecular Immunology
|
November 1, 1993
Human IgG3 can adopt the disulfide bond pattern characteristic for IgG1 without resembling it in complement mediated cell lysis
O H Brekke, B Bremnes, R Sandin, et al.
Page
of 2
Search research articles
Search
Showing results (1-10 of 16) with videos related to
Sort By:
Page
of 2
Current Opinion in Pharmacology
|
October 16, 2003
New technologies in therapeutic antibody development
O H Brekke, G Å Løset
Immunology Today
|
February 1, 1995
The structural requirements for complement activation by IgG: does it hinge on the hinge?
O H Brekke, T E Michaelsen, I Sandlie
Biological Chemistry
|
February 14, 1998
Identification and characterisation of C1q-binding phage displayed peptides
V Lauvrak, O H Brekke, O Ihle, et al.
Nature
|
September 5, 1996
Activation of complement by an IgG molecule without a genetic hinge
O H Brekke, T E Michaelsen, R Sandlin, et al.
Nature
|
June 17, 1993
Activation of complement by an IgG molecule without a genetic hinge
O H Brekke, T E Michaelsen, R Sandin, et al.
Protein Engineering, Design & Selection : PEDS
|
October 11, 2007
Functional phage display of two murine alpha/beta T-cell receptors is strongly dependent on fusion format, mode and periplasmic folding assistance
G Å Løset, E Lunde, B Bogen, et al.
European Journal of Immunology
|
July 1, 1993
The extended hinge region of IgG3 is not required for high phagocytic capacity mediated by Fc gamma receptors, but the heavy chains must be disulfide bonded
A Aase, I Sandlie, L Norderhaug, et al.
European Journal of Immunology
|
October 1, 1994
Human IgG isotype-specific amino acid residues affecting complement-mediated cell lysis and phagocytosis
O H Brekke, T E Michaelsen, A Aase, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
October 21, 1998
Comparisons of the ability of human IgG3 hinge mutants, IgM, IgE, and IgA2, to form small immune complexes: a role for flexibility and geometry
K H Roux, L Strelets, O H Brekke, et al.
Molecular Immunology
|
November 1, 1993
Human IgG3 can adopt the disulfide bond pattern characteristic for IgG1 without resembling it in complement mediated cell lysis
O H Brekke, B Bremnes, R Sandin, et al.
Page
of 2